Aug. 11 at 3:54 PM
$SANA $ELDN $DXCM $PODD $TNDM Fellow T1D Investors, this is more of a very exciting PSA to us T1D's than an investing opportunity as Endo Axium is not publicly traded. It is an Australian based company I have been following for a couple years now. They are beginning testing on an oral insulin that is encapsulated in glucose responsive nanoparticles, meaning as blood sugar rises, the nanoparticles release insulin, in humans. I listed their peer review a while back, and they had normoglycemia, meaning no hypos or high bs, in baboons (or maybe gorillas, or something like that I forget off the top of my head). For us T1D's this potentially means just swallowing a pill every 3 days and forgetting we even have T1D! Let's hope it works!!! Even more exciting Sana's SC451 should be entering ph1/2 in the next coming months!!! We have so much good stuff coming!!!!! LFG!!!
